U of M students' bug trap invention keeps Japanese beetles out of gardens
U of M students create a way of dealing with an invasive insect
U of M students create a way of dealing with an invasive insect
Some University of Minnesota students have come up with a creative solution for a pesky problem.
"Every year these Japanese beetles would come and completely eat away at our plum trees," said Aditya Prabhu. "My mom would drag me and my brother outside and pick them by hand."
Prabhu knew there had to be a better way to deal with the invasive insects. And he found his solution in an entrepreneur class at the University of Minnesota.
It challenged Prabhu and classmate Mohamed Hammadelniel to think outside the box. So, they created a trap that could stop the bugs dead in their tracks, while also being environmentally-friendly.
"The pheromone is fairly simple. It's a little cone inside the trap," said Prabhu.
That pheromone attracts Japanese beetles to the trap's mesh, which is coated in a low dose insecticide. It's not a threat to humans, animals, or pollinators, but it is to beetles.
"When beetles land on it, it takes them about 30 seconds to be killed by the insecticide," said Prabhu.
During a test run at two Minnesota vineyards, hundreds of beetles filled the traps and they were nearly bursting at the seams. It's been such a success that Prabhu, Hammadelniel and their friend James won the Minnesota Cup competition, and took home $25,000 to move the invention forward.
"I don't think I expected it to be something that after a year, was still so meaningful to all three of us," said Hammadelniel.
The goal now is to take their invention a step further. They're hoping these plant traps become a common site in gardens across the state.
"It's going to be absolutely cool to see this in stores," said Prabhu.
"I hope we can reach as many people and as many beetles as possible," said Hammadelniel. "That's really the goal. If we can continue to inspire students to innovate in college, as well as solving a real problem, I'd feel really at peace."
Prabhu says the official name is the Alure beetle trap, Alure LLC. Their next step is to do more research this summer and then get Environmental Protection Agency registration, which would give them the rights to manufacture, market and sell the trap.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fox News
27 minutes ago
- Fox News
Men face double dementia risk if they have a hidden genetic mutation
A hidden genetic mutation could predict a man's likelihood of developing dementia. That's according to an Australian study led by Monash and Curtin Universities, which analyzed the medical data of thousands of Australians and Americans. Men who had a certain variant in the haemochromatosis (HFE) gene — which regulates iron levels in the body — were found to be at a higher risk of dementia, the researchers found. Previously healthy men over age 70 who have two copies of the variant, which is known as H63D, are at least twice — or up to four times — as likely to develop dementia. Having just one copy did not appear to elevate the risk. One in 36 men carry two copies of the mutation; one in three have just a single copy. "It is only men who have two copies of the variant that are at risk," study co-author Professor John Olynyk from the Curtin Medical School told Fox News Digital. "Women are not affected by the abnormality – we do not know why that is at the current point in time." The study, which was published in the journal Neurology, used data from the ASPirin in Reducing Events in the Elderly (ASPREE) trial, which gathered health and aging data for 19,114 healthy older adults. Those who have the genetic variant can't change it, but it's possible that the "brain pathways" it affects could be treated, Olynyk noted. "The HFE gene is routinely tested for in most Western countries … when assessing people for haemochromatosis, a disorder that causes the body to absorb too much iron," the doctor said. "Our findings suggest that perhaps this testing could be offered to men more broadly." Despite the fact that the HFE gene is responsible for controlling iron levels, the team found no direct link between iron and dementia risk. "Our findings suggest that perhaps this testing could be offered to men more broadly." "This points to other mechanisms at play, possibly involving the increased risk of brain injury from inflammation and cell damage in the body," Olynyk added. More research is needed to determine why the heightened risk wasn't seen in women. "Understanding why men with the double H63D variant are at higher risk could pave the way for more personalized approaches to prevention and treatment," added co-author Professor Paul Lacaze from Monash University in a press release. The main limitation of the study, according to Olynyk, was that the study population was largely composed of Australians. "Whether other populations exhibit the same effects is unclear," he told Fox News Digital. "Our work should be repeated in different countries to assess this." "Further research will be undertaken to try and determine the likely mechanism by which this anomaly causes dementia and what more we can do to reduce the impact of it." Beyond this specific mutation, many other genetic and environmental factors can contribute to dementia risk, Olynyk noted. "While genetic risk factors cannot be changed, the mechanisms by which these genetic abnormalities and environmental factors cause disease may well be modifiable to some extent, through adopting a healthy lifestyle and being proactive about maintaining an overall good state of health," he said. To reduce risk, the researchers recommend adopting a healthy lifestyle that includes exercising regularly, eating a nutritious diet, minimizing alcohol intake, remaining mentally active, and seeing a doctor to address any medical problem known to increase the likelihood of dementia. For more Health articles, visit The University of Melbourne, The Royal Children's Hospital, Murdoch Children's Research Institute and Fiona Stanley Hospital also contributed to the study.
Washington Post
30 minutes ago
- Washington Post
Trump administration says it won't publish major climate change report on NASA website as promised
WASHINGTON — The Trump administration on Monday took another step to make it harder to find major, legally mandated scientific assessments of how climate change is endangering the nation and its people. Earlier this month, the official government websites that hosted the authoritative, peer-reviewed national climate assessments went dark. Such sites tell state and local governments and the public what to expect in their backyards from a warming world and how best to adapt to it. At the time, the White House said NASA would house the reports to comply with a 1990 law that requires the reports , which the space agency said it planned to do.
Yahoo
32 minutes ago
- Yahoo
Weight loss drugs can boost testosterone in men, study finds
Popular weight loss medications like Ozempic can help reverse low testosterone levels in men with obesity or Type 2 diabetes, according to new research. Building on previous studies that show weight loss surgery or lifestyle changes can increase testosterone levels in the body, researchers at SSM Health St. Louis University Hospital analyzed the electronic health records of 110 men with obesity or Type 2 diabetes to monitor changes in the hormone while taking GLP-1 receptor agonists, such as semgalutide and tirzepatide. They measured testosterone levels before taking the medications and for 18 months after starting the treatment. Roughly half of the men had low to low-normal testosterone at the start of the study and most reached normal levels after treatment. The mean age of the participants was 54. 'The increases we observed were more modest than what you would typically see with testosterone replacement therapy,' said lead author Dr. Shellsea Portillo Canales, endocrinologist at SSM Health St. Louis University Hospital, via email. 'However, they occurred naturally, without testosterone replacement therapy (TRT), and likely reflect the body recovering its normal hormone production as weight and insulin resistance improved.' The study highlights the need for men already on testosterone therapies to closely monitor their levels after starting weight loss medications, Portillo said. In some cases, men may need to have their testosterone supplement doses lowered or discontinued, especially if their testosterone normalizes while on weight loss medications. There are limitations to the new study. The findings don't prove the increase in testosterone levels was caused by the drugs semaglutide or tirzepatide. It was a retrospective study, meaning the researchers analyzed existing medical records over time, rather than conducting a randomized clinical trial. And they didn't check testosterone levels after the men stopped the drugs. 'If weight is regained, testosterone levels could potentially drop again,' Portillo said. The study findings were presented this Monday at ENDO 2025, the Endocrine Society's annual meeting in San Francisco. The researchers are planning to submit it to a medical journal for peer review. Dr. Susan Spratt, professor of medicine at Duke University School of Medicine, said many men are overtreated with testosterone therapy when they have levels on the lower normal side. 'It would be better to treat obesity or diabetes and naturally increase testosterone than to prescribe testosterone — which has known risks,' said Spratt, who was not part of the study. Some risks of testosterone therapy include worsening sleep apnea, acne, enlarging the prostate or breasts, increasing growth of prostate cancer, reducing sperm counts, causing the testicles to shrink and increasing the risk of clots, according to Mayo Clinic. The study shows the dual benefit of weight loss medications in men, said Dr. Fatima Cody Stanford, obesity medicine physician scientist at Massachusetts General Hospital and Harvard Medical School. 'The findings from this study highlight an important intersection between metabolic health and hormonal balance,' Stanford said. 'This dual benefit underscores the potential of these medications to enhance overall health outcomes, including reproductive health, in this population.' Normal testosterone levels are between 300 to 1,000 nanograms per deciliter. Testosterone tends to decline gradually with age, starting around the late 30s to early 40s. By age 75, the average male testosterone level drops to about 65% of the average level seen in young adults, Portillo said. 'Improving testosterone can enhance quality of life and possibly reduce health risks associated with low levels,' Portillo said. Spratt said it's important to distinguish between normal testosterone levels that increase but remain in the normal range, versus low testosterone levels that increase to normal. Testosterone levels that are truly low are most concerning because low testosterone can lower bone density (which increases the risk of fracture), reduce muscle mass, lower hemoglobin (red blood cells) levels and decrease libido, experts say. 'However, treating low normal testosterone without a known cause is controversial and has increased in the past decade likely due to direct-to-consumer marketing,' Spratt said. The researchers only included men in the study, because they didn't expect weight loss drugs to raise testosterone levels in women. 'In general, we don't routinely measure testosterone in women, unless there are signs of a hormonal imbalance, like excess facial hair (hirsutism), irregular periods, infertility or signs of masculinization,' Portillo said. In those cases, testosterone testing can help diagnose conditions like polycystic ovary syndrome, or PCOS, adrenal disorders or rare tumors. Some studies in women with PCOS, a condition which raises testosterone levels, suggest GLP-1 therapies may help slightly lower testosterone by improving metabolism and reducing insulin resistance. Certain conditions are well known to decrease testosterone in men, including excess fat, especially around the abdomen, which interferes with hormone signals from the brain to the testicle, experts say. 'Fortunately, weight loss, whether through lifestyle changes or medications, can reverse it in many cases,' Portillo said. This article was originally published on
